Cargando…
Network pharmacology to explore the mechanism of scutellarin in the treatment of brain ischaemia and experimental verification of JAK2/STAT3 signalling pathway
Scutellarin is used to treat brain ischaemia. However, its underlying mechanism of action remains unclear. This study aimed to elucidate the potential mechanism of action of scutellarin in brain ischaemia through network pharmacology and experimental verification. The JAK2/STAT3 signalling pathway w...
Autores principales: | Jia, Qiu-Ye, Chen, Hao‑Lun, Qi, Zhi, Zhang, Xiao‑Li‑Na, Zheng, Li-Yang, Liu, Teng-Teng, Yuan, Yun, Yang, Li, Wu, Chun‑Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169761/ https://www.ncbi.nlm.nih.gov/pubmed/37160937 http://dx.doi.org/10.1038/s41598-023-33156-5 |
Ejemplares similares
-
Pharmacological basis for application of scutellarin in Alzheimer's disease: Antioxidation and antiapoptosis
por: Hu, Xinyu, et al.
Publicado: (2018) -
Scutellarin attenuates microglia activation in experimentally induced hypoxia-ischemia brain damage by down-regulating miRNA-7036a: Scutellarin suppresses microglia mediated inflammation
por: Jia, Wenji, et al.
Publicado: (2023) -
Preparation and characterization of scutellarin loaded on ultradeformable nano-liposomes scutellarin EDTMP (S-UNL-E) and in vitro study of its osteogenesis
por: Minhua, Teng, et al.
Publicado: (2022) -
Network pharmacology mechanism of Scutellarin to inhibit RGC pyroptosis in diabetic retinopathy
por: Li, Na, et al.
Publicado: (2023) -
Scutellarin inhibits proliferation and invasion of hepatocellular carcinoma cells via down‐regulation of JAK2/STAT3 pathway
por: Liu, Kang, et al.
Publicado: (2019)